When.com Web Search

  1. Ad

    related to: treatment for progressive supranuclear palsy

Search results

  1. Results From The WOW.Com Content Network
  2. Progressive supranuclear palsy - Wikipedia

    en.wikipedia.org/wiki/Progressive_supranuclear_palsy

    Progressive supranuclear palsy (PSP) is a late-onset neurodegenerative disease involving the gradual deterioration and death of specific volumes of the brain. [ 1 ] [ 2 ] The condition leads to symptoms including loss of balance , slowing of movement , difficulty moving the eyes , and cognitive impairment . [ 1 ]

  3. Parkinson-plus syndrome - Wikipedia

    en.wikipedia.org/wiki/Parkinson-plus_syndrome

    Parkinson-plus syndromes are usually more rapidly progressive and less likely to respond to antiparkinsonian medication than PD. [10] [11] However, the additional features of the diseases may respond to medications not used in PD. [citation needed] Current therapy for Parkinson-plus syndromes is centered around a multidisciplinary treatment of ...

  4. Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Parkinson's_disease

    Differentiating early PD from atypical parkinsonian disorders is a major difficulty. In their initial stages, PD can be difficult to distinguish from the atypical neurodegenerative parkinsonisms, including MSA, dementia with Lewy bodies, and the tauopathies progressive supranuclear palsy and corticobasal degeneration.

  5. What Is PSP? All About Progressive Supranuclear Palsy ... - AOL

    www.aol.com/psp-progressive-supranuclear-palsy...

    Science & Tech. Shopping. Sports

  6. For premium support please call: 800-290-4726 more ways to reach us

  7. Deulinoleate ethyl - Wikipedia

    en.wikipedia.org/wiki/Deulinoleate_ethyl

    In 2020, the FDA granted orphan drug designation deulinoleate ethyl for the treatment of patients with progressive supranuclear palsy (PSP). PSP is a disease involving modification and dysfunction of tau protein; mechanism of action of deulinoleate ethyl both lowers lipid peroxidation and prevents mitochondrial cell death of neurons which is ...

  8. Retrotope - Wikipedia

    en.wikipedia.org/wiki/Retrotope

    In 2020 FDA granted orphan drug designation RT001 for the treatment of patients with progressive supranuclear palsy (PSP). PSP is a disease involving modification and dysfunction of tau protein; RT001's mechanism of action both lowers lipid peroxidation and prevents mitochondrial cell death of neurons which is associated with disease onset and ...

  9. Frontotemporal dementia - Wikipedia

    en.wikipedia.org/wiki/Frontotemporal_dementia

    Related disorders are corticobasal syndrome (CBS or CBD), and progressive supranuclear palsy (PSP). ... Treatments are available to manage the behavioral symptoms ...